期刊
CURRENT RADIOPHARMACEUTICALS
卷 5, 期 3, 页码 187-201出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1874471011205030187
关键词
Titanium-44; Scandium-44; Radionuclide generator; Post-processing; DOTA; Octreotide; Positron emission; PET
资金
- COST [D38, BM0607]
- DFG [DFG RO 985 / 18]
Ti-44/(44) Sc radionuclide generators are of interest for molecular imaging. The 3.97 hours half-life of Sc-44 and its high positron branching of 94.27% may stimulate the application of Sc-44-labeled PET radiopharmaceuticals. This review describes the current status of Ti-44 production, Ti-44/(44) Sc radionuclide generator development, post-processing of generator eluates towards medical application, identification of ligands adequate to Sc-III co-ordination chemistry, proof-of-principle labeling of Sc-44-DOTA-octreotides, investigation of in vitro and in vivo parameters, and initial applications for molecular imaging - both in small animals and humans.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据